Multiple comparisons, interaction effects, and statistical inference: Lessons from chronic kidney disease progression among blacks

Kidney International

Volumn 81, Issue 6, 2012, Pages 516-519

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; HYDROCHLOROTHIAZIDE; SIMVASTATIN;

ALBUMINURIA; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ETHNIC GROUP; FALSE POSITIVE RESULT; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; NEGRO; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; STATISTICAL ANALYSIS;

EID: 84857764296     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.442     Document Type: Note

References (7)

1. Weir MR, Bakris GL, Weber MA et al. Renal outcomes in hypertensive Black patients at high cardiovascular risk. K idney Int 2012; 81: 568-576.
2. Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
3. Bakris GL, Sarafidis PA, Weir MR et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. L ancet 2010; 375: 1173-1181.
4. Holden JE, Kelley K, Agarwal R. Analyzing change: a primer on multilevel models with applications to nephrology. A m J Nephrol 2008; 28: 792-801.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
6. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192.
7. Kjeldsen SE, Jamerson KA, Bakris GL et al. Predictors of systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study, Blood Press advance online publication, 10 August 2011